1,367
Views
9
CrossRef citations to date
0
Altmetric
Clinical Features - Original Research

Physicians’ knowledge of potential covid-19 drug–drug interactions: An online survey in turkey

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 237-241 | Received 20 May 2020, Accepted 06 Aug 2020, Published online: 25 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Valeria Conti, Nicola Bertini, Rosaria Ricciardi, Berenice Stefanelli, Emanuela De Bellis, Carmine Sellitto, Marco Cascella, Francesco Sabbatino, Graziamaria Corbi, Pasquale Pagliano & Amelia Filippelli. (2024) Adverse events related to drug–drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review. Expert Opinion on Drug Metabolism & Toxicology 20:4, pages 275-292.
Read now
Muhammad Zeeshan Munir, Amer Hayat Khan & Tahir Mehmood Khan. (2024) Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19. Expert Review of Anti-infective Therapy 0:0, pages 1-7.
Read now
Alessandro Cuomo, Giovanni Barillà, Gianluca Serafini, Andrea Aguglia, Andrea Amerio, Matteo Cattolico, Pietro Carmellini, Alessandro Spiti & Andrea Fagiolini. (2023) Drug-drug interactions between COVID-19 therapeutics and psychotropic medications. Expert Opinion on Drug Metabolism & Toxicology 19:12, pages 925-936.
Read now

Articles from other publishers (6)

Atsushi Miyawaki, Kei Kitajima, Akihiro Iwata, Daichi Sato & Yusuke Tsugawa. (2024) Physician characteristics associated with antiviral prescriptions for older adults with COVID-19 in Japan: an observational study. BMJ Open 14:3, pages e083342.
Crossref
Nadir Yalcin & Kutay Demirkan. (2023) Management of drug-related problems including drug–drug interactions caused by nirmatrelvir/ritonavir in paediatric patients with SARS-CoV-2. Archives of Disease in Childhood 108:10, pages e16-e16.
Crossref
Jesús Cebrino & Silvia Portero de la Cruz. (2023) Polypharmacy and associated factors: a gender perspective in the elderly Spanish population (2011–2020). Frontiers in Pharmacology 14.
Crossref
LUIZA GABUNIA, MANANA GHONGHADZE, GIGI GORGADZE, GIORGI VARAZI, NINO KIKVADZE, ANA TVALABEISHVILI, NATALIA FILIPETS & LONDA RUKHADZE. (2022) PREVENTION OF COMPLICATIONS IN COVID-PATIENTS TAKING INTO ACCOUNT THE KEY ISSUES OF POLYPHARMACY, RATIONAL PHARMACOTHERAPY. EXPERIMENTAL & CLINICAL MEDICINE GEORGIA.
Crossref
Hooman Ghasemi, Niloofar Darvishi, Nader Salari, Amin Hosseinian-Far, Hakimeh Akbari & Masoud Mohammadi. (2022) Global prevalence of polypharmacy among the COVID-19 patients: a comprehensive systematic review and meta-analysis of observational studies. Tropical Medicine and Health 50:1.
Crossref
Zeinab Mohseni Afshar, Arefeh Babazadeh, Alireza Janbakhsh, Masomeh Bayani, Elham Ramezani, Arezoo Salami Khaneshan & Soheil Ebrahimpour. (2021) A review of cardiovascular involvements associated with medications used to treat COVID-19 infection. Cor et Vasa 63:3, pages 359-363.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.